Bill

Bill > HB2158


PA HB2158

PA HB2158
Further providing for schedules of controlled substances.


summary

Introduced
01/26/2026
In Committee
01/26/2026
Crossed Over
Passed
Dead

Introduced Session

2025-2026 Regular Session

Bill Summary

Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for schedules of controlled substances.

AI Summary

This bill amends The Controlled Substance, Drug, Device and Cosmetic Act to update the list of controlled substances, specifically by adding new language to Schedule I, which contains substances with a high potential for abuse and no accepted medical use in the United States. The amendment clarifies that any synthetic, semi-synthetic, or chemically manipulated form of certain alkaloids derived from the Mitragyna speciosa plant, including mitragynine and 7-hydroxymitragynine, will be considered a controlled substance if it meets specific concentration thresholds or is a derivative or analogue of these compounds. This change aims to regulate substances that may pose a risk to public health and safety by bringing them under the purview of existing drug control laws.

Committee Categories

Justice

Sponsors (7)

Last Action

Referred to Judiciary (on 01/26/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...